Answers are grounded in this paper and cite their sources.
This case report describes a child with acute lymphoblastic leukemia who developed thrombocytopenia, suggesting immune thrombocytopenic purpura could be a diagnosis.
In patients with acute lymphoblastic leukemia (ALL), thrombocytopenia is most commonly attributed to chemotherapy-induced myelosuppression or disease relapse. We report the case of a 6 years young girl who developed isolated thrombocytopenia during the 12th week of maintenance therapy with 6-mercaptopurine and methotrexate. Despite discontinuation of chemotherapy for two weeks, her platelet counts did not improve. Multiple platelet transfusions were administered without response. Bone marrow examination revealed a hypercellular marrow with adequate megakaryocytes, suggesting peripheral platelet destruction, possibly secondary to chemotherapy. She was subsequently treated with a short course of steroids, as per her COG maintenance protocol, to which she responded well. This case underscores the importance of considering secondary immune thrombocytopenia (ITP) as a differential diagnosis in ALL patients on maintenance chemotherapy who present with persistent isolated thrombocytopenia.
No takes yet. Share an insight, caveat, or question.
Ambedare et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: